BioSpace News Archive

Five Prime Therapeutics, Inc. will join the Pancreatic Cancer Action Network (PanCAN) PurpleStride San Francisco.

Revance Therapeutics, Inc. announced that the Company will participate in the Jefferies 2018 Global Healthcare Conference in New York, NY.

McKesson Corporation announced that Britt Vitalone, executive vice president and chief financial officer, will present at the Goldman Sachs 39th Annual Global Healthcare Conference.

Theravance Biopharma, Inc. highlighted that a regulatory application for once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI 100/62.5/25 mcg) under the proposed brand name Trelegy Ellipta has been submitted to the Japanese Ministry of Health, Labour and Welfare (MHLW).

Magellan Health, Inc. announced that Swati Abbott and Matthew J. Simas have been elected at the 2018 annual meeting of shareholders to Magellan’s board of directors.

People from across the U.S. who are living with sleep apnea will gather in College Park, Maryland, on June 8, 2018 to share what it’s like to live with sleep apnea with FDA regulators, drug and medical device developers, and researchers.

As an OBGYN one of the most common office questions is the infamous “Is this safe in pregnancy?”

PetalMD pursues its growth by enlarging its services through the acquisition of Xacte.

European medical device company BrainCool AB (publ) has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its second product in the United States, the IQoolTM Warm System, with an indication for use of thermal regulation to cool and rewarm adult patients when clinically indicated

Mint Innovation has already taken its technology from laboratory to pilot stage and it is now seeking around US$4 million to build its first commercial scale plant.